Skip to main content
Equibles

NFSG Corp

Position in ABBV — AbbVie Inc.

CIK 1879757 BOCA RATON, FL
Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,281,368
+$381,593 QoQ
Shares Held
9,066
+3.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,871
of 4,176 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

NFSG Corp holds $13,230,148 across 16 Drug Manufacturers - General names. ABBV ranks #2 (17.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 5,038 $6,042,728
2 ABBV
AbbVie Inc.
This page 		9,066 $2,281,368
3 JNJ
Johnson & Johnson
 7,757 $1,970,045
4 MRK
Merck & Co., Inc.
 13,054 $1,677,439
5 PFE
Pfizer Inc
 12,510 $301,240
6 AMGN
Amgen Inc
 716 $259,277
7 GSK
GSK plc
 4,417 $231,539
8 AZN
Astrazeneca PLC
 1,128 $213,891

All Filings in ABBV

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,281,368 9,066
2026-03-31 $1,899,775 8,735
2025-12-31 $1,967,984 8,613
2025-09-30 $2,239,917 9,674
2025-06-30 $1,789,933 9,643
2025-03-31 $2,153,446 10,278
2024-12-31 $1,940,484 10,920
2024-09-30 $675,184 3,419
2024-06-30 $674,073 3,930
2024-03-31 $1,259,767 6,918
2023-12-31 $988,243 6,377
2023-09-30 $1,063,543 7,135
2023-06-30 $1,009,666 7,494
2023-03-31 $1,310,340 8,222
2022-12-31 $1,310,495 8,109
2022-09-30 $1,088,577 8,111
2022-06-30 $1,216,243 7,941
2022-03-31 $1,183,565 7,301
2021-12-31 $762,572 5,632
2021-09-30 $563,189 5,221
2021-06-30 $543,938 4,829
2021-03-31 $491,427 4,541
2020-12-31 $427,957 3,994
2020-09-30 $384,870 4,394